i&i Prague

Overview

i&i Prague is a biotech incubator and venture builder dedicated to fostering early-stage life sciences companies in Central and Eastern Europe. The organization specializes in drug development, diagnostics, medical technologies, and other life sciences sectors, providing comprehensive support to startups from inception through commercialization. Their services include market analysis, industry feedback, initial funding, and connections to potential investors, aiming to bridge the gap between scientific innovation and market success. In 2021, i&i Prague, in collaboration with the European Investment Fund, established the i&i Biotech Fund I, a venture capital firm with over €53 million under management. This fund focuses on investing in innovative European life sciences companies, particularly in drug discovery, medical devices, diagnostics, and digital health. The fund targets early-stage investments, with typical funding ranging from €150,000 to €2 million, supporting companies in the seed, Series A, and Series B stages. The team at i&i Prague comprises professionals with extensive experience in academia, technology transfer, and industry, enabling them to effectively identify and nurture promising biotech projects. Their approach emphasizes a strong network of startups, investors, industrial partners, and biotechnology experts, facilitating collaboration and knowledge sharing to accelerate the growth of life sciences innovations in the region.

Investment Focus

• Innovative life sciences projects with high market potential
• Early-stage companies seeking seed to Series B funding
• Startups based in Central and Eastern Europe, with a focus on the European Union member states

Portfolio Companies